Accelerating Clinical NGS Ecosystem Development Together
Accelerationg Clinical NGS Ecosystem Development Together
The MGI Partner NGS Application Enablement Program is designed to foster collaboration across the genomics ecosystem and support the development of innovative applications and workflows on DNBSEQ sequencing platforms. Through strategic partnerships with assay developers, technology providers, and genomics innovators, MGI helps accelerate application development, expand sequencing capabilities, and drive the adoption of advanced genomic solutions. Together, we aim to address evolving market needs and create new opportunities for scientific and commercial growth.
Who Should Apply?
Designed for partners developing innovative CE-IVD applications, assays, and sequencing workflows across the molecular diagnostics and genomics ecosystem.
Why Partner With MGI?
Access the DNBSEQ Product Portfolio
Utilize different DNBSEQ platforms at the Berlin CEC or partners sites
Collaborate and Optimize
Technical evaluation and workflow validation
The MGI Partner NGS Application Enablement Program is designed to foster collaboration across the genomics ecosystem and support the development of innovative applications and workflows on DNBSEQ sequencing platforms. Through strategic partnerships with assay developers, technology providers, and genomics innovators, MGI helps accelerate application development, expand sequencing capabilities, and drive the adoption of advanced genomic solutions. Together, we aim to address evolving market needs and create new opportunities for scientific and commercial growth.
Who Should Apply?
Designed for partners developing innovative CE-IVD applications, assays, and sequencing workflows across the molecular diagnostics and genomics ecosystem.
Why Partner With MGI?
Partner with MGI,
Build the future of clinical NGS workflows together.
The MGI Partner NGS Application Enablement Program is designed to foster collaboration across the genomics ecosystem and support the development of innovative applications and workflows on DNBSEQ sequencing platforms. Through strategic partnerships with assay developers, technology providers, and genomics innovators, MGI helps accelerate application development, expand sequencing capabilities, and drive the adoption of advanced genomic solutions. Together, we aim to address evolving market needs and create new opportunities for scientific and commercial growth.
Who Should Apply?
Designed for partners developing innovative CE-IVD applications, assays, and sequencing workflows across the molecular diagnostics and genomics ecosystem.
Why Partner With MGI?
Access the DNBSEQ Product Portfolio
Utilize different DNBSEQ platforms at the Berlin CEC or partners sites
Collaborate and Optimize
Technical evaluation and workflow validation
Partner with MGI,
Build the future of clinical NGS workflows together.
Accelerating Clinical NGS Ecosystem Development Together
Join our newsletter to stay up to date on features and releases.
I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.
*For Research Use Only
Not for use in diagnostic procedures (except as specifically noted).
Join our newsletter to stay up to date on features and releases.
I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.
*For Research Use Only
Not for use in diagnostic procedures (except as specifically noted).
Join our newsletter to stay up to date on features and releases.
I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.
*For Research Use Only
Not for use in diagnostic procedures (except as specifically noted).